BioMarin Pharmaceutical Inc. Buys Zacharon Pharmaceuticals, Inc. for $10 Million

Published: Jan 08, 2013

BioMarin Pharmaceutical Inc. bought Zacharon Pharmaceuticals of San Diego for $10 million. Novato-based BioMarin (NASDAQ: BMRN) may pay more in the deal, depending on whether Zacharon hits certain milestones. Zacharon is working on treatments aimed at mucopolysaccharidosis disorders and also diseases like Tay Sachs and Sandhoff.

Back to news